Pharmaceutical Current Events | Pharmaceutical News
|
| Page
1 of
9 |
173 Results |
|
|
|
Sort By:
Page Views | Date |
POLYMUN Scientific to present at the 4X4 pour entrepreneur
POLYMUN Scientific, together with 20 other companies, has been selected from 300 submissions to present its innovative pharmaceutical projects at the prestigious "Taste of Entrepreneurship: Financing and Research" symposium in Louvain-La-Neuve, Belgium, Nov. 19 and 20, 2002. POLYMUN will present its pharmaceutical projects in view of the newest... view more... (2002-11-15)
Calling The Pharmaceutical Industry To Account (p 1682)
The final article in THE LANCET's series about the relationship between the pharmaceutical industry and medicine is published this week-the author concluding that there is still some way to go before industry can truly be deemed accountable to global public-health needs. Graham Dukes, an independent medico-legal author attached to the University... view more... (2002-11-20)
Relations between the drug industry and patient groups should be open
Relationships between the pharmaceutical industry and patients’ organisations must be at arm’s length and transparent, and not affect the agenda and priorities of these groups, argues a senior doctor in this week’s BMJ. view more (2003-05-28)
The Pharmaceutical Industry As Political Player (p 1498)
The second of four articles about the relationship between the pharmaceutical industry and medicine focuses on the political dynamic between industry and regulatory authorities. John Abraham from the University of Sussex, Brighton, UK, discusses how political frameworks designed to govern the pharmaceutical industry must, on the... view more... (2002-11-06)
Dr Brian Gennery appointed Deputy Head of The Postgraduate Medical School at UniS
The Postgraduate Medical School at the University of Surrey is delighted to announce the recent appointment of Dr Brian Gennery as Deputy Head of School and Vice-Dean of Medicine as from 1 March 2005. Dr Gennery joined PGMS in 2002 and has been the Programme Director for the MSc in Pharmaceutical Medicine. view more (2005-03-08)
Over 6% of admissions to one unit related to pharmaceutical drugs; and over two thirds avoidable
More than 6% of admissions to one medical unit over six months were related to pharmaceutical drugs, reveals a study in Quality and Safety in Health Care. And over two thirds of these cases were potentially avoidable, concludes the research. view more (2003-08-01)
Should drug companies be allowed to talk to patients?
If people are to become more involved in their own health care, they must be able to gain access to high quality, balanced, accurate, and up to date information, but should this information come from drug companies? In this week's BMJ, Trevor Jones of the Association of the British Pharmaceutical Industry and Wendy Garlick of the Consumers'... view more... (2003-06-12)
Pharmaceutical sector backs biotechnology
There is a long tradition of pharmaceutics in Germany and foreign trade figures show that the German pharmaceutical industry is successful on an international level. However, there have been large structural shifts in this sector due to the developments in modern biotechnology. With regard to the science intensive drug research there are many... view more... (2002-01-29)
Is Science Stuck In The Middle Ages? (p 339)
This week's editorial discusses some of the problems that biomedical scientists face in their career paths as the structure of research is changing from small-scale investigator-led research to large-scale "discovery science", such as the Human Genome Project. Discussing a recent book by the US National Academies, the editorial comments... view more... (2003-07-30)
Disclosure laws provide only limited view of pharmaceutical company payments to physicians
Laws in two states requiring disclosure of pharmaceutical company payments to physicians do not provide the public with easy access to payment information and are of limited quality when accessed. view more (2007-03-21)
Palladium and platinum an easier find with Pitt researcher's detection method
Finding uses for palladium and platinum--rare precious metals coveted by the automobile, chemical, and pharmaceutical industries as catalysts in chemical reactions-proves easier than finding the scarce materials themselves. view more (2007-09-24)
A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. view more (2007-03-02)
10 per cent of human genome is target for new drugs
Around 10 per cent of the human genome can be targeted for the development of new drugs, according to top pharmaceutical industry scientists speaking at the BA Festival of Science at the University of Glasgow today [3rd September 2001]. Speaking at the From genes and cells to healthcare forum organised by the Biotechnology and Biological Sciences... view more... (2001-08-30)
Potential pharmaceutical drugs in the field of cancer
Raquel Villar Becares, in her PhD thesis at the Public University of Navarre, has developed new derivatives of benzo[b]tiophene 1,1-dioxide that enable their application in the pharmaceutical field. view more (2005-12-23)
High-dose Radiotherapy Could Reduce Cognitive Function For People With Low-grade Brain Tumours (p 1361)
Authors of an article in this week's issue of THE LANCET-the first of a series of four articles assessing the role of the pharmaceutical industry in medicine-are critical of the way in which multinational pharmaceutical companies manipulate the provision of information, and say that this contributes to a distortion of medical... view more... (2002-10-30)
New £6m biocentre to revolutionise the production of safer medicines
The University of Manchester has been awarded £6m to open a new biocentre which will revolutionise the way future medicines are produced - making them safer and more effective. view more (2005-03-14)
Pharmaceutical Interests Versus AIDS In Africa (p 89)
The appointment of Randall Tobias as the US Government's global AIDS co-ordinator is analysed in this week's editorial. Tobias will head up a $15 billion programme to tackle AIDS in the African and Caribbean countries most devastated by the pandemic, although sceptics point out that his lack of knowledge about Africa and his pharmaceutical... view more... (2003-07-09)
Action needed to tackle fake drugs trade
The World Health Organisation estimates that fake drugs account for 10% of global pharmaceutical commerce. Researchers in this week’s BMJ call for urgent international action to tackle this murderous trade. Recent examples of fake drugs include neomycin eye drops and meningococcal vaccine made of tap water; paracetamol syrup made of... view more... (2002-04-03)
Health of independent clinical trials in danger, scientist warns
European Union legislation due to take effect next year could have a disastrous effect on non-commercial clinical trials, said a leading cancer researcher today. Speaking at ECCO 12 - The European Cancer Conference in Copenhagen, Professor Fran'§oise Meunier, Director General of the EORTC1 Brussels, Belgium, told a news briefing that the new... view more... (2003-09-22)
Who owns genetic information?
Who owns genetic information? view more (2002-05-24)
|
|
| Page
1 of
9 |
173 Results |
|
|
|
Sort By:
Page Views | Date |
|
